Default Category
-
Mayo Clinic: The 2020 Initiative
Herzlinger, Regina E.; Huckman, Robert S.; Lesser, JennyCase HBS-615027-EDescribes the challenges facing Dr. John Noseworthy, President and CEO, in implementing a long-term strategy for the growth of the Mayo Clinic-a leading academic medical center with a reputation for excellence in tertiary and quaternary health care. The case highlights the concurrent forces of regional and national competition and federal health care reform as factors complicating the plans of Mayo Clinic to grow through several channels. Student...Starting at €8.20
-
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
Herzlinger, Regina E.; Otazo, AndrewCase HBS-315045-EEntrepreneurshipA medical device startup seeks to complete its clinical trials with very little startup funding and a small staff when compared to its competitors.Starting at €8.20
-
McKesson
Herzlinger, Regina E.; Kindred, NatalieCase HBS-312002-EMcKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010 revenues, just made its first foray into health care services with the acquisition of U.S. Oncology, an integrated cancer care company, whose expertise it could leverage in offerings catered to other physician specialties. Wi...Starting at €8.20
-
Cancer Treatment Centers of America (A)
Herzlinger, Regina E.; Kindred, NatalieCase HBS-313012-EService and Operations ManagementCancer Treatment Centers of America (CTCA), a U.S. network of four privately owned oncology focused factory hospitals, was weighing options for growth. CTCA was entirely cancer focused and specialized in treating patients with complex and advanced-stage cancers, who were reached through advertising its integrative, team-based approach to care. CEO Stephen Bonner needed to decide whether to focus future expansion on building additional full-scale ...Starting at €8.20
-
Shanghai Pharmaceuticals
Herzlinger, Regina E.; Kindred, NatalieCase HBS-313016-EStrategyShanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company-essentially a collection of subsidiaries operating under a unified management structure-was formed through the 2009 merger of several state-owned enterprises, part of a broad policy effort in China to streamline state assets, ...Starting at €8.20
-
-
Boston Properties (A)
Taliaferro, Ryan D.; Sesia, AldoCase HBS-211018-EFinanceInvestment manager Eliza Baena confronts an apparent convertible bond arbitrage opportunity when she notices a narrowing spread between two Boston Properties (BXP) bonds, one a convertible bond and the other a straight bond, in the wake of the 2008 Lehman bankruptcy. Baena must decide if there is an opportunity, how to structure a trade to exploit it, and how much of her fund's capital to allocate. Case exposition includes descriptions of basic f...Starting at €8.20
-
Boston Properties (B)
Taliaferro, Ryan D.; Sesia, AldoCase HBS-211041-EFinanceThe B case briefly recounts the action that investment manager Eliza Baena takes in the matter of the Boston Properties (BXP) bonds described in the A case. She must decide what to do next.Starting at €5.74
-
Fixed Income Arbitrage in a Financial Crisis (B): US Treasuries in December 2008
Taliaferro, Ryan D.; Blyth, StephenCase HBS-211050-EFinanceThe B case briefly recounts the action that investment manager James Franey takes in the matter of two U.S. Treasury bonds with identical maturity dates but widely different yields. He must decide what to do next.Starting at €5.74
-
La Universidad de Trent
Herzlinger, Regina E.Case HBS-117S13Accounting and ControlSe centra en dos cuestiones: 1) Sistemas de técnicas que se pueden emplear en las organizaciones sin ánimo de lucro para el control y propósitos de motivación. Sistemas discuten gama de sistemas de seguimiento de nómina a los presupuestos de base cero y 2) el entorno de gestión necesarias para los esfuerzos de control graves a tener lugar.Starting at €8.20